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This study compared acute (15 min) yoga posture and guided meditation practice, performed seated in a typical oﬃce workspace,
on physiological and psychological markers of stress. Twenty participants (39.6 ± 9.5yr) completed three conditions: yoga,
meditation, and control (i.e., usual work) separated by ≥24hrs. Yoga and meditation signiﬁcantly reduced perceived stress versus
control, and this eﬀect was maintained postintervention. Yoga increased heart rate while meditation reduced heart rate versus
control (P<0.05). Respiration rate was reduced during yoga and meditation versus control (P<0.05). Domains of heart
rate variability (e.g., SDNN and Total Power) were signiﬁcantly reduced during control versus yoga and meditation. Systolic and
diastolic blood pressure were reduced secondary to meditation versus control only (P<0.05). Physiological adaptations generally
regressedtowardbaselinepostintervention.Inconclusion,yogaposturesormeditationperformedintheoﬃcecanacutelyimprove
several physiological and psychological markers of stress. These eﬀects may be at least partially mediated by reduced respiration
rate.
1.Introduction
Psychological stress in the workplace is an independent risk
factor for cardiometabolic diseases and associated mortality
[1–4]. For example, a recent meta-analysis concluded that
chronic and excessive work stress can increase the risk of
myocardial infarction by 50% [2].
The link between stress and disease is mediated by
endocrine pathways of the sympathetic nervous system
(SNS), including the hypothalamus-pituitary-adrenal (HPA)
axis [5, 6]. Cortisol, the main eﬀector of the HPA axis,
increases circulating fatty acid and glucose concentrations
and inhibits the action of insulin. SNS activation becomes
particularly problematic in a sedentary work environment
as psychological stress compounded by physical inactiv-
ity triggers hyperlipidemia [7] and hyperglycemia, known
antecedents to advanced cardiovascular and metabolic dis-
eases [8, 9].
Yoga and meditation are forms of complementary and
alternative medicine that have become popular in recent
decadesasmethodsofmanagingstressandimprovinghealth
status. Investigations conducted in nonwork settings have
shown that a single session of yoga postures or guided
meditation can improve psychological and physiological
markers of SNS activation. Acute yoga and/or meditation
practice have been shown to reduce perceived stress [10, 11],
blood pressure [11], heart rate [11] and respiration rate
[12], and increase vagal autonomic modulation evaluated
via heart rate variability (HRV) [13]. By contrast, sedentary
oﬃce work has been shown to increase perceived stress,
blood pressure, and heart rate and reduce measures of HRV
[14, 15].2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Timeline for the assessment of outcome measures. Noncontinuous measures collected at Timepoints 1 to 5 and continuous
measures collected in phases 1 to 7.
It is often diﬃcult for individuals to commit to regular
stress-reducing practice due to time restrictions incurred by
work and family life. Brief bouts of yoga or meditation in the
workplace could be a potential method to counteract stress.
However, to date, no trial has evaluated the eﬀectiveness of
such practices.
The purpose of this study was to compare the eﬀect
of acute yoga posture and guided meditation practice, per-
formedwhileseatedintheoﬃceworkspace,onphysiological
and psychological markers of stress. We hypothesized that
both practices would elicit a relaxation response versus the
continuationofusualoﬃcework(control)evaluatedviaself-
perceived stress, blood pressure, heart rate, respiration rate,
and time and frequency domains of HRV.
2. Methods
2.1. Study Design. This was an exploratory study involving
a within-subjects crossover design. Participants completed
three conditions, including yoga postures, guided medi-
tation, and control, separated by ≥24 hours. Participants
were randomized via randomization schedule (http://www
.randomization.com/) and were blind to their allocation
until after the completion of the baseline assessment. The
University of Western Sydney Human Research Ethics Com-
mittee approved all study procedures, and written informed
consent was obtained from all participants.
2.2. Participants
Inclusion Criteria. (i) adult (≥18y), (ii) employed full-time
in a sedentary (i.e., oﬃce-based) position, (iii) English
language suﬃcient to understand research procedures and
provide written informed consent, and (iv) willingness to
undergo study protocols.
Exclusion Criteria. (i) uncontrolled illness, (ii) use of medi-
cation known to alter heart rate or blood pressure, and (iii)
acute or chronic medical condition that would impede the
assessment of outcome measures.
2.3. Procedure. A demonstration of the yoga and meditation
practices was provided at least one day prior to the ﬁrst
testing session. Each testing session was completed in the
oﬃce or cubicle workspace of the participant, at a pre-
arranged time, during regular oﬃce hours. Participants were
advised to follow the same meal and beverage patterns on
each testing day. All three assessments were completed at
precisely the same time of day. Participants were asked to
turn oﬀ their oﬃce and mobile telephones during each
testing session. The testing equipment was portable and set-
upwithminimaldisruptiontotheusualworkactivitiesofthe
participant. A timeline of the study procedure is presented in
Figure 1.
2.3.1. Baseline (5Min). The purpose of the 5-min baseline
assessment was to collect physiological and psychological
data reﬂective of usual oﬃce work. Participants were there-
fore instructed to continue with their work as usual. Minor
movements such as mouse clicking or typing were allowed;
however, major arm, leg, or trunk movements or rising from
the chair, were to be avoided.
2.3.2. Intervention (15Min). Immediately following the
baseline assessment, participants performed one of the three
conditions(yoga,meditationorcontrol)fora15minperiod.
2.3.3. Postintervention (15Min). The purpose of the 15min
postintervention assessment was to evaluate the eﬀect of
intervention withdrawal. During this period, participants
were instructed to resume their usual work adhering to
the same movement restrictions applied during the baseline
assessment.
2.4. Interventions
2.4.1. Yoga. Participants were instructed to perform ﬁfteen
minutes of gentle yoga postures while seated in their chair.
The intervention, described in detail by Diab [16], involved
several postures (e.g., side bend, forward bend, back bend,
arms above head and extended); each posture was held for
six full breaths (inhalation plus exhalation), approximately
from30to60seconds,andthecyclewasrepeatedasrequired.
A brief relaxation period involving eyes closed and no
movement was also included during this intervention. The
intervention integrated deep breathing and was speciﬁcally
designed to induce relaxation [16].
2.4.2. Meditation. Participants performed ﬁfteen minutes of
guided meditation instructed by a prerecorded mp3 ﬁleEvidence-Based Complementary and Alternative Medicine 3
Table 1: Participant characteristics (n = 20).
Age (years) 39.6 ± 9.5
Sex (men:women) 8:12
Height (cm) 169 ± 12
Body mass (kg) 70.0 ± 16.3
Body mass index (kg/m2)† 22.5
(19.8–44.1)
Occupation (n)
Academic staﬀ (lecturer and researcher) 11
Administrative staﬀ 4
Researcher 2
Research assistant 2
Campus facility manager 1
Yoga/meditation practice over previous year (n)
Did not practice 14
Practiced 1 to 3 times per month 3
Practiced 1 to 2 times per week 1
Practiced 3 times per week 2
Data reported according to mean ± standard deviations for normally
distributed variables.
†Nonnormal distribution: median values and range reported.
(Debra McCormack, Sydney, Australia, 2010), delivered via
Ipod (Apple, Cupertino, California, USA) and headphones
(TDK NC-150; Tokyo Denki Kagaku, Nihonbashi, Japan).
The practice emphasized deep breathing, visualization, and
alleviating internal dialogue. Participants were instructed to
follow the instructions as closely as possible.
2.4.3. Control. Participants were instructed to continue with
their oﬃce work with the same movement and talking
restrictions as applied during the baseline recording.
2.5. Outcome Measures. Perceived stress and blood pressure
were collected at timepoints 1 to 5 (T1–T5) (Figure 1).
Perceived stress was evaluated by means of a 100mm
visual analogue on which participants rated their state of
stress/relaxation at that particular moment, ranging from
“ExtremeRelaxation”(0mm)to“ExtremeStress”(100mm).
A score of 50mm was designated “Neutral”. Systolic and
diastolic blood pressures were evaluated via auscultation.
Heart rate, respiration rate, and time and frequency
domains of HRV were recorded continuously. Data were
analysedinseven5minphasesincluding1 ×5minrecording
at baseline (P1), 3 × 5min recordings during the interven-
tion (P2–P4), and 3 × 5min recordings postintervention
(P5–P7).
Respiration rate was evaluated using a PowerLab 26T
Advanced Teaching System and a Piezo Respiratory Belt
Transducer attachment (ML856 and MLT1132, ADInstru-
ments, Castle Hill, Australia) placed level with the umbilicus.
DatawererecordedinLabChart7.1.Respirationrate(inhala-
tionplusexpiration)inbreathsperminutewascalculatedfor
each 5min phase.
Heart rate and HRV were recorded using a telemetric
Polar Heart Rate Monitor (Polar, RS800sd, Kempele, Fin-
land). The polar RS800 is functionally equivalent to the S810
model,whichhasbeenvalidatedforshort-termrecordingsof
HRV[17,18].PertinenttimeandfrequencydomainsofHRV
were assessed, including SDNN (i.e., standard deviation of
normal-normal intervals), Total Power (TP; i.e., the variance
of all normal-normal intervals), the Low Frequency (LF)
power component (0.04 to 0.15Hz) measured in absolute
(ms2)andrelative(%)units,theHighFrequency(HF)power
component (0.15 to 0.4Hz) measured in absolute (ms2)a n d
relative(%)units,andtheLowFrequencytoHighFrequency
Ratio (LF:HF). Low measures of HRV including low TP and
low SDNN are signiﬁcant and independent risk factors for
coronary artery disease [19] and all-cause mortality [20].
Data were imported into ProTrainer 5 software (Version
5.35.165, Polar, Kempele, Finland) and inspected visually
for artefact (caused by ectopic beats, arrhythmic events,
electromagnetic radiation, etc.). Data were then imported
into Kubios Version 2.0 HRV software (Biosignal Analysis
andMedicalImagingGroup,DepartmentofAppliedPhysics,
UniversityofKuopi,Finland)fordeterminationofheartrate,
and time and frequency domains of HRV [21].
2.6. Statistical Analyses. All available data were included in
statistical analyses performed using the Statistical Package
for the Social Sciences Version 18.0 (SPSS, Somers, NY). All
data were inspected visually and statistically for normality.
Normally distributed data were described using mean ±
standard deviation or mean ± standard error, as indicated,
and nonnormally distributed data were described using
median and ranges. Nonnormally distributed continuous
variables were log-transformed prior to entry into para-
metric statistical models. Contrast analysis was used to test
the diﬀerence in the change score from baseline (T1 or
P1) to each subsequent phase or timepoint between the
control condition and yoga or meditation separately. Similar
contrast analysis was used to compare the diﬀerence between
yoga and meditation conditions. P<0.05 was considered
indicative of statistical signiﬁcance.
3. Results
3.1. Participants. Participant characteristics are presented
in Table 1. Twenty adults were recruited and completed
all procedures. Body mass index (BMI) ranged from 19.8
to 44.1kg/m2 and two individuals fulﬁlled the criteria for
obesity (BMI ≥ 30.0kg/m2). One obese participant also
had type 2 diabetes. Additional controlled diseases in the
cohort included asthma (n = 3), chronic fatigue (n = 2),
and hypertension (n = 1). No participant had a history
of tobacco use. The majority of participants held academic
positions involving teaching and research and did not engage
in yoga and/or meditation practice over the previous year.
3.2. Outcome Measures. All data are presented in full in
Tables 2 and 3.
3.2.1. Perceived Stress. Perceived stress was signiﬁcantly
reduced immediately postyoga and postmeditation versus
control, and these eﬀects were maintained throughout the
postintervention period (Figure 2). There was no signiﬁcant4 Evidence-Based Complementary and Alternative Medicine
Table 2: Timepoint data.
T1 T2 T3 T4 T5
Systolic BP (mmHg)
Control 116.70 ± 12.38 115.25 ± 11.71 116.30 ± 13.48 114.80 ± 11.99 114.85 ± 12.98
Yoga 111.70 ± 13.42 110.85 ± 13.31 109.35 ± 13.51 109.95 ± 10.40 110.35 ± 12.56
Meditation 114.55 ± 12.17 110.15 ± 13.03 109.05 ± 13.32 113.50 ± 11.52 114.15 ± 12.50
P (C versus Y) 0.700 0.378 0.942 0.830
P (C versus M) 0.187 0.028∗ 0.753 0.516
P (Y versus M) 0.111 0.166 0.777 0.726
Diastolic BP (mmHg)
Control 76.55 ± 11.17 76.80 ± 10.84 77.95 ± 11.07 77.00 ± 10.20 78.05 ± 10.07
Yoga 75.40 ± 11.52 76.45 ± 11.38 76.30 ± 10.68 76.25 ± 9.35 76.10 ± 11.18
Meditation 77.55 ± 10.67 75.95 ± 11.26 75.60 ± 10.25 76.45 ± 10.18 77.65 ± 10.61
P (C versus Y) 0.616 0.806 0.829 0.677
P (C versus M) 0.259 0.041∗ 0.358 0.459
P (Y versus M) 0.119 0.223 0.446 0.785
Perceived stress (0–100)
Control 59.50 ± 11.57 59.10 ± 11.95 59.20 ± 12.17 59.25 ± 11.99 59.70 ± 11.57
Yoga 56.15 ± 9.80 46.60 ± 13.97 49.20 ± 11.57 50.65 ± 10.36 51.90 ± 11.04
Meditation 58.60 ± 9.36 45.70 ± 13.57 47.70 ± 12.46 49.15 ± 11.61 49.85 ± 11.46
P (C versus Y) 0.003∗ 0.007∗ 0.007∗ 0.018∗
P (C versus M) 0.000∗ 0.000∗ 0.002∗ 0.003∗
P (Y versus M) 0.154 0.088 0.219 0.189
Data presented in mean ± standard deviation; BP: blood pressure; Y: yoga; C: control; M: meditation.
∗Change from baseline (T1) statistically signiﬁcant between groups.
change in perceived stress between yoga and meditation at
any timepoint.
3.2.2. Blood Pressure. Changes in systolic and diastolic blood
pressure were not signiﬁcantly diﬀerent between yoga versus
control or yoga versus meditation at any timepoint; however,
both systolic and diastolic blood pressure were signiﬁcantly
reduced in meditation versus control at T3 (see Tables 2 and
3).
3.2.3. Respiration Rate. Respiration rate decreased by 24.6%
(mean of P2–P4) during yoga and increased 8.9% during
control (Figure 3). Both eﬀects regressed toward the baseline
value during the postintervention period. Respiration rate
signiﬁcantly decreased by 16.8% (mean of P2–P4) during
meditation versus control (P<0.0 5 )a n dr e g r e s s e dt o w a r d
the baseline value postintervention. No signiﬁcant diﬀer-
ences were noted between yoga and meditation.
3.2.4. Heart Rate. Yoga signiﬁcantly increased heart rate by
6.5%(meanofP2–P4)versuscontrol(Figure 4).Bycontrast,
meditation signiﬁcantly reduced heart rate versus control in
P 2a n dP 3 ,w i t hat r e n dn o t e di nP 4( −3.9%, mean of P2–
P4). Change in heart rate was signiﬁcantly diﬀerent between
yogaandmeditationthroughouttheinterventionperiod.No
condition × time eﬀects were noted postintervention.
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Figure 2: Perceived stress. Data presented as mean ± standard
error.Percentagechangevaluesrefertochangefrombaselinewithin
condition. ∗Statistically signiﬁcant versus control.
3.2.5.HRVTimeDomains. SDNNincreasedduringyogaand
decreased during control, and the diﬀerence between condi-
tions was signiﬁcant (Figure 5). The most notable increase
in SDNN during yoga (P2, +22.5%) coincided with theEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: Respiration rate. Data presented as mean ± standard
error. Percentage change values refer to change from baseline
within condition. ∗Statistically signiﬁcant versus control. Y: yoga;
M: meditation; C: control.
initiation of physical postures, while the diﬀerence in P3 and
P4 was mediated by the large decrease in SDNN during con-
trol.ThechangeinSDNNwassigniﬁcantlydiﬀerentbetween
meditation and control during P2 only, and this diﬀerence
was also mediated by the large decrease in SDNN in control.
There was a notable decrease in SDNN during meditation in
P3 and trend toward increased SDNN in meditation versus
control in P4 and P5. SDNN signiﬁcantly increased in yoga
versus meditation during P2 only, with a trend noted in P3.
3.2.6. HRV Frequency Domains. Total Power (TP) and abs-
olute HF and LF power components were not normally dis-
tributed and were therefore normalized via logarithmic
transformation prior to analysis with parametric statistical
models.
Theﬁndingsforlog-TPweresimilartothoseobtainedfor
SDNN. Log-TP increased during yoga and decreased during
control, and the diﬀerence was primarily mediated by the
largedecreaseincontrol(Figure 6).Theabsol u t eandr elati v e
LF components increased during yoga versus control in
P2 and P3 (see Tables 2 and 3). LF measures were not
diﬀerent between yoga and control in P4. Yoga also induced
a decrease in the relative HF power component and an
increase in LF:HF in P2 and P3. No other eﬀects were noted
between yoga and control, except that log-LF and LF:HF
were signiﬁcantly reduced during yoga versus control in P7.
Log-TP was signiﬁcantly reduced in control versus med-
itation during P2 only (Figure 6). This change was accom-
panied by increased or trend toward increased absolute and
relative LF components, a trend toward reduced relative HF
component, and a trend toward increased LF:HF ratio in
meditation versus control (see Tables 2 and 3). No other
diﬀerences were noted between meditation and control.
Log-TP signiﬁcantly increased in yoga versus meditation
in P2, and this change was accompanied by a trend toward
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Figure 4: Heart rate. Data presented as mean ± standard error.
Percentage change values refer to change from baseline within
condition. ∗Statistically signiﬁcant versus control. †Statistically
signiﬁcant versus yoga. Y: yoga; M: meditation; C: control.
increased absolute and relative LF components and a trend
toward reduced relative HF component (see Tables 2 and
3). During P3, log-TP and the absolute and relative LF
components signiﬁcantly increased, while relative HF was
signiﬁcantly reduced, in yoga versus meditation. The LF:HF
ratio increased or tended to increase with yoga versus
meditation during P2, P3, and P4. No other diﬀerences were
noted between yoga and meditation.
4. Discussion
This study evaluated the eﬀect of brief yoga posture and
meditation practice, performed while seated in the oﬃce
workspace, on physiological and psychological markers of
stress. Both yoga and meditation reduced perceived stress
versus the control condition (i.e., the continuation of regular
oﬃce work), and these eﬀects were maintained throughout
the 15min postintervention period (Figure 2). Physiological
responses also indicated a relaxation eﬀect during yoga and
meditation.
The adaptation of certain physiological outcome mea-
sures during yoga or meditation practice, such as SDNN
and log-TP, was mediated by increased stress during control.
It could, therefore, be hypothesized that the 5min baseline
recording in all conditions reﬂected an artiﬁcial state in
which greater parasympathetic modulation may have been
the product of interaction between the participant and
tester (e.g., touching, for the purpose of evaluating blood
pressure). Postintervention responses in every condition
demonstrated a return to the baseline value, indicating that
interaction between the participant and tester may have
exerted relaxation during this period as well. Thus, in a true
workplace situation, the parasympathetic inﬂuence would
likely be lower, as observed in SDNN and log-TP measures
during P2–P4.6 Evidence-Based Complementary and Alternative Medicine
Table 3: Phase data.
P1 P2 P3 P4 P5 P6 P7
Respiration rate
Control 13.87 ± 1.95 15.04 ± 2.57 15.20 ± 2.26 14.73 ± 2.17 14.31 ± 1.88 13.86 ± 1.49 14.25 ± 1.42
Yoga 13.68 ± 2.32 10.43 ± 2.46 10.06 ± 2.43 10.07 ± 2.12 12.92 ± 1.89 14.06 ± 2.56 14.09 ± 1.89
Meditation 14.30 ± 1.79 11.47 ± 2.14 11.97 ± 3.63 12.36 ± 3.44 13.78 ± 2.18 13.84 ± 1.83 14.21 ± 1.68
P (C versus Y) 0.000∗ 0.000∗ 0.000∗ 0.023∗ 0.573 0.960
P (C versus M) 0.000∗ 0.000∗ 0.006∗ 0.106 0.470 0.349
P (Y versus M) 0.591∗ 0.169 0.075 0.623 0.118 0.350
Heart Rate
Control 73.98 ± 10.65 72.51 ± 10.20 72.71 ± 9.98 72.97 ± 10.01 71.65 ± 9.83 72.23 ± 9.48 71.71 ± 9.28
Yoga 73.19 ± 9.37 77.47 ± 8.95 77.80 ± 9.09 77.82 ± 7.95 71.51 ± 7.75 70.92 ± 8.50 71.08 ± 7.85
Meditation 73.59 ± 9.66 70.56 ± 10.90 70.75 ± 10.70 71.22 ± 9.30 72.53 ± 9.69 71.06 ± 9.38 71.32 ± 9.64
P (C versus Y) 0.000∗ 0.000∗ 0.000∗ 0.315 0.570 0.860
P (C versus M) 0.032∗ 0.015∗ 0.098 0.135 0.369 0.999
P (Y versus M) 0.000∗ 0.000∗ 0.000∗ 0.465 0.744 0.870
SDNN
Control 76.27 ± 37.35 59.01 ± 31.23 59.41 ± 28.41 59.70 ± 26.06 67.32 ± 22.15 65.99 ± 23.96 67.63 ± 26.25
Yoga 68.89 ± 22.02 82.62 ± 25.35 71.59 ± 23.24 72.53 ± 30.59 72.19 ± 23.71 63.98 ± 17.16 69.00 ± 22.98
Meditation 69.49 ± 22.78 70.92 ± 34.50 60.44 ± 31.68 68.45 ± 27.05 76.82 ± 29.79 67.50 ± 25.26 67.99 ± 21.00
P (C versus Y) 0.000∗ 0.009∗ 0.007∗ 0.093 0.396 0.191
P (C versus M) 0.019∗ 0.367 0.104 0.086 0.259 0.179
P (Y versus M) 0.033∗ 0.055 0.332 0.354 0.503 0.638
Log-TP (ms2)
Control 3.66 ± 0.35 3.42 ± 0.46 3.42 ± 0.42 3.40 ± 0.37 3.57 ± 0.38 3.53 ± 0.42 3.54 ± 0.37
Yoga 3.61 ± 0.35 3.78 ± 0.32 3.65 ± 0.35 3.58 ± 0.40 3.60 ± 0.32 3.47 ± 0.33 3.48 ± 0.31
Meditation 3.61 ± 0.38 3.62 ± 0.43 3.44 ± 0.47 3.51 ± 0.35 3.68 ± 0.35 3.55 ± 0.35 3.57 ± 0.34
P (C versus Y) 0.001∗ 0.003∗ 0.026∗ 0.264 0.977 0.916
P (C versus M) 0.013∗ 0.510 0.202 0.070 0.317 0.377
P (Y versus M) 0.112 0.017 0.369 0.222 0.221 0.313
Log-LF (ms2)
Control 3.00 ± 0.38 2.85 ± 0.51 2.84 ± 0.50 2.90 ± 0.40 3.02 ± 0.37 2.93 ± 0.44 2.99 ± 0.41
Yoga 3.06 ± 0.40 3.47 ± 0.40 3.22 ± 0.42 3.11 ± 0.55 3.09 ± 0.41 2.91 ± 0.43 2.88 ± 0.33
Meditation 2.99 ± 0.34 3.13 ± 0.57 2.88 ± 0.69 2.96 ± 0.51 3.08 ± 0.40 3.02 ± 0.41 2.95 ± 0.42
P (C versus Y) 0.001∗ 0.003∗ 0.234 0.986 0.270 0.047∗
P (C versus M) 0.048∗ 0.714 0.594 0.266 0.287 0.751
P (Y versus M) 0.072 0.040∗ 0.437 0.365 0.064 0.138
LF (n.u.)
Control 69.79 ± 14.31 66.12 ± 15.44 67.52 ± 15.22 71.39 ± 16.22 68.72 ± 17.48 70.67 ± 15.87 70.44 ± 18.24
Yoga 72.68 ± 12.34 88.85 ± 6.75 80.47 ± 13.76 76.75 ± 21.24 76.40 ± 10.76 71.12 ± 14.36 66.77 ± 12.78
Meditation 70.44 ± 12.83 76.32 ± 19.11 63.53 ± 24.40 70.67 ± 18.96 75.78 ± 13.35 70.28 ± 19.50 66.04 ± 16.65
P (C versus Y) 0.001∗ 0.065 0.697 0.301 0.501 0.145
P (C versus M) 0.098 0.478 0.801 0.157 0.819 0.326
P (Y versus M) 0.056 0.019∗ 0.455 0.688 0.781 0.707
Log-HF (ms2)
Control 2.60 ± 0.47 2.53 ± 0.53 2.48 ± 0.50 2.45 ± 0.48 2.61 ± 0.45 2.50 ± 0.49 2.55 ± 0.50
Yoga 2.62 ± 0.51 2.52 ± 0.44 2.56 ± 0.44 2.50 ± 0.54 2.55 ± 0.48 2.47 ± 0.44 2.56 ± 0.37
Meditation 2.58 ± 0.53 2.51 ± 0.55 2.59 ± 0.56 2.51 ± 0.45 2.53 ± 0.50 2.57 ± 0.52 2.61 ± 0.42
P (C versus Y) 0.582 0.541 0.789 0.146 0.437 0.749
P (C versus M) 0.915 0.129 0.374 0.500 0.357 0.365
P (Y versus M) 0.620 0.527 0.605 0.766 0.128 0.171Evidence-Based Complementary and Alternative Medicine 7
Table 3: Continued.
P1 P2 P3 P4 P5 P6 P7
HF (n.u.)
Control 30.22 ± 14.31 33.89 ± 15.44 32.49 ± 15.22 28.61 ± 16.22 28.71 ± 15.85 29.34 ± 15.87 29.57 ± 18.24
Yoga 27.32 ± 12.34 11.16 ± 6.75 19.54 ± 13.76 23.26 ± 21.24 23.60 ± 10.76 28.89 ± 14.36 33.24 ± 12.78
Meditation 29.56 ± 12.83 23.68 ± 19.11 36.47 ± 24.40 29.33 ± 18.96 24.22 ± 13.35 29.72 ± 19.50 33.96 ± 16.65
P (C versus Y) 0.001∗ 0.065 0.697 0.589 0.501 0.145
P (C versus M) 0.098 0.478 0.801 0.361 0.819 0.326
P (Y versus M) 0.056 0.019∗ 0.455 0.688 0.781 0.707
LF:HF
Control 3.21 ± 2.53 2.55 ± 1.57 3.04 ± 2.44 3.90 ± 2.91 3.27 ± 2.15 3.34 ± 2.06 3.89 ± 3.06
Yoga 3.61 ± 2.63 13.27 ± 12.38 6.00 ± 3.86 8.10 ± 8.80 4.22 ± 2.43 3.38 ± 2.28 2.81 ± 2.81
Meditation 3.12 ± 2.03 7.57 ± 10.89 3.45 ± 3.42 4.21 ± 4.11 4.62 ± 3.35 4.31 ± 3.88 3.26 ± 3.35
P (C versus Y) 0.003∗ 0.015∗ 0.080 0.380 0.529 0.024∗
P (C versus M) 0.075 0.593 0.734 0.089 0.254 0.466
P (Y versus M) 0.069 0.024∗ 0.108 0.292 0.107 0.178
Data presented in mean ± standard deviation; Y: yoga; C: control; M: meditation.
∗Change from baseline (P1) statistically signiﬁcant between groups.
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Figure 5: SDNN. Data presented as mean ± standard error.
Percentage change values refer to change from baseline within
condition. ∗Statistically signiﬁcant versus control. †Statistically
signiﬁcant versus meditation. Y: yoga; M: meditation; C: control.
Both yoga and meditation reduced the respiration rate
comparedtocontrol(Figure 3).Theyogaposturesintegrated
deep breathing, while the guided mediation instructed the
listener to slow and deepen their breath. The control
condition increased respiration by 8.9%. This may have been
accompanied by shallow breathing. Studies have shown that
deep breathing techniques can acutely improve baroreceptor
sensitivity and reduce blood pressure [22, 23]. By contrast,
shallow breathing can increase SNS activity [24]. Studies
are required to investigate the diﬀerential eﬀects of yoga
and meditation versus general deep breathing exercises to
determine if the relaxation eﬀects are primarily explained by
respiration.
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Figure 6: Log-Total Power. Data presented as mean ± standard
error.Percentagechangevaluesrefertochangefrombaselinewithin
condition. ∗Statistically signiﬁcant versus control. †Statistically
signiﬁcant versus meditation. Y: yoga; M: meditation; C: control.
Respiration was not signiﬁcantly diﬀerent between yoga
postures and meditation at any timepoint (Figure 4). How-
ever, respiration gradually increased throughout the medita-
tion intervention while this eﬀect was not observed during
yoga. The diﬀerence could be attributed to the meditation
instruction. Breathing became less emphasized and visual-
ization became more emphasized over the course of the
meditationsession.Ourcohorthadminimalexperiencewith
meditation, and lack of direct attention on the breath may
have contributed to the gradual increase in respiration.
Treatment eﬀects noted for HRV time and frequency
domains during yoga and meditation may have been inﬂu-
enced by respiration. Deep breathing is known to increase8 Evidence-Based Complementary and Alternative Medicine
parasympathetic modulation [25]. Previous studies have
attempted to control for respiration [26]. However, this can
adversely aﬀect the therapeutic potential of the intervention.
SDNN and log-TP both increased in yoga relative to control
during the intervention period (Figures 5 and 6 from P2 to
P4). This is notable given that reduced ambulatory SDNN
and TP are associated with the development of coronary
artery disease [19] and all-cause mortality [20].
The improvement of TP during yoga versus control was
accompanied by increased or a trend toward increased log-
LF, relative LF, and the LF:HF ratio during P2 and P3.
This largest increase in these parameters was detected in P2,
duringtheinitiationofphysicalpostures.TheLFcomponent
reﬂects both sympathetic and parasympathetic modulation
[25]. Interventions known to increase sympathetic activity
(e.g., vigorous exercise) reduce TP and SDNN and generally
increase blood pressure [25]. However, TP and SDNN were
increased, while there was no change in blood pressure with
yoga, suggesting that changes in the LF component during
P2 and P3 of yoga were not primarily due to increased
sympatheticinputs.Pengetal.[27]notedincreasedLFpower
and reduced respiration rate in experienced meditators
during practice. The adaptations were interpreted to reﬂect
increasedrespiratorysinusarrhythmiaandvagalmodulation
[27]. Similar ﬁndings have been documented in a Zen
meditation study [28].
The meditation condition signiﬁcantly increased SDNN
and TP versus control during P2 only. These eﬀects were
accompanied by an increase in log-LF. The sharp reduction
i nS D N Na n dl o g - T Pf r o mP 2t oP 3m a yh a v eb e e nd u et o
the speciﬁc instruction, compounded by the relative inex-
perience of our cohort. From 7:26 to 11:08min, the guided
meditation contained a silent section of no instruction. It
may have been diﬃcult for our participants, predominantly
inexperienced meditators, to maintain a quiet mind during
this period. Thoughts about work or daydreaming may have
elicited an increase in SNS activation.
Trends toward increased SDNN and log-TP in medita-
tion versus control were noted in P4 and during the ﬁrst
postinterventionphase(P5).Thus,signiﬁcantimprovements
during the intervention and postintervention (residual
eﬀect) may have been observed with a larger sample size,
more experienced meditators, and/or removal of the silent
section of the guided meditation.
The yoga intervention resulted in a greater number of
physiological beneﬁts than the guided meditation condition.
It could be hypothesized that the performance of yoga
postures is required to facilitate a quiet mind, particularly in
individuals employed in professions that require signiﬁcant
mental focus, such as academic work. This supports the
position that individuals in westernized countries beneﬁt
from performing yoga postures prior to meditation [29].
Heart rate throughout the intervention period (from P2
to P4) was diﬀerent between yoga and meditation practice.
However, the relatively small (6.5%) increase in heart rate
with yoga indicates that the chair-based yoga postures were
only a very mild form of exertion. Other diﬀerences between
yoga and meditation included enhanced time and frequency
domains of HRV in the early stages of intervention period
(from P2 to P3) favouring a relaxation response in yoga.
Yoga and meditation had a residual eﬀect on per-
ceived stress as the beneﬁts were maintained throughout
the 15min postintervention period (Figure 3). By contrast,
physiologicaladaptationselicitedbyallconditions(i.e.,yoga,
meditation, and control) generally regressed to baseline
values during the 15min postintervention period (from P5
to P7). The main exception was respiration rate, which
remained signiﬁcantly reduced in yoga versus control in
P5. More experienced practitioners may have derived more
residual beneﬁts from intervention, though further research
is required to conﬁrm this hypothesis.
Log-LF and LF:HF were signiﬁcantly reduced in yoga
relative to control in P7, while RMSSD was signiﬁcantly
higher in meditation versus control in P6. It is not clear
whether these were actual residual eﬀects or anomalies.
Systolic and diastolic blood pressure signiﬁcantly
decreased in the meditation condition versus control at T3
only, while no change was noted in blood pressure with
yoga. However, our cohort was normotensive at baseline,
and as such an improvement of blood pressure would not
be expected. Future studies inducing a stress response just
prior to prescribing a stress-reducing intervention may be
able to facilitate a rise in systolic and diastolic blood pressure
in normotensive oﬃc ew o r k e r si nf u t u r et r i a l s .S t u d i e s
conducted in patients with hypertension have shown that
meditation can reduce systolic and diastolic blood pressure
[30, 31].
In summary, this study suggests that participation in 15
minutes of chair-based yoga postures or guided meditation
in the oﬃce workspace can acutely improve several physi-
ological and psychological markers of stress. These eﬀects
maybeatleastpartiallymediatedbyreducedrespirationrate.
Long-term utilization of these practices to mitigate stress in
the workplace may result in signiﬁcant health-related bene-
ﬁts, including the reduced risk of cardiometabolic diseases.
Randomised controlled trials to investigate such hypotheses
in various sedentary occupations are recommended.
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